Aplastic anemia complicating Sjögren's syndrome

Aplastic anemia and Sjögren's syndrome are both rare conditions, and their co-occurrence is even less common. Aplastic anemia is characterized by bone marrow failure and pancytopenia, while Sjögren's syndrome is an autoimmune disease affecting exocrine glands. Prior research has shown that Sjögren's syndrome may involve lymphocytic infiltration in salivary glands. However, the mechanisms linking these two conditions remain unclear. No prior work had resolved how one might influence the other. That uncertainty drove the need for case reports to expand clinical understanding. This gap motivated the documentation of rare cases to improve diagnostic and therapeutic approaches. The sicca symptoms in Sjögren's syndrome are well-documented, but their overlap with hematological symptoms can obscure diagnosis. Understanding this overlap is essential for timely and accurate treatment.

This case report aimed to document a rare instance of aplastic anemia occurring in a patient with Sjögren's syndrome. The patient presented with severe anemia and polyclonal gammopathy, followed by sicca symptoms. The purpose was to highlight the diagnostic challenges and treatment outcomes in such a rare combination. The motivation stemmed from the limited literature on this association. The case provides insight into the clinical presentation and management of these overlapping conditions. The authors sought to emphasize the importance of considering autoimmune etiologies in patients with unexplained pancytopenia. The study also aimed to demonstrate the potential for successful treatment with immunosuppressive therapy. By presenting this case, the authors intended to contribute to the growing body of evidence on rare hematological complications of autoimmune diseases.

The study involved a clinical case report of a 47-year-old woman with severe anemia and polyclonal gammopathy. Laboratory tests were conducted to assess blood cell counts and gamma globulin levels. Bone marrow biopsy was performed to evaluate marrow cellularity. Histological examination of the salivary gland was carried out to confirm lymphocytic infiltration. The patient was treated with immunosuppressive therapy, and her response was monitored. Clinical and laboratory data were collected to track changes in symptoms and blood parameters. The study did not include a control group or comparative analysis. The focus was on the individual patient's response to treatment and the correlation between her symptoms and laboratory findings.

The patient exhibited pancytopenia with white blood cells at 2,800/microliter, hemoglobin at 6.4 g/dl, and platelets at 6.1 x 10⁴/microliter. Bone marrow was found to be hypoplastic, indicating aplastic anemia. Hyper gamma globulinemia was measured at 5.2 g/dl. Histology of the salivary gland showed lymphocytic infiltration, consistent with Sjögren's syndrome. The patient developed sicca symptoms after admission. Immunohistochemical analysis confirmed the autoimmune nature of the condition. The patient responded well to immunosuppressive therapy, showing improvement in blood parameters. The treatment led to a reduction in lymphocytic infiltration and normalization of gamma globulin levels.

The authors concluded that aplastic anemia can complicate Sjögren's syndrome, and this case report provides evidence of a successful treatment response to immunosuppressive therapy. The combination of pancytopenia and hyper gamma globulinemia in this patient supported the diagnosis of both conditions. The histological findings confirmed the presence of Sjögren's syndrome. The response to treatment suggests that immunosuppressive therapy may be effective in managing this rare association. The case highlights the importance of considering autoimmune etiologies in patients with unexplained pancytopenia. The authors propose that early diagnosis and appropriate treatment can lead to favorable outcomes. The study does not suggest that immunosuppressive therapy is the only treatment option. The findings may help guide future clinical decisions in similar cases.